What Pre-Treatment Protocols Should Medical Aesthetic Clinics Establish For Patients Undergoing Ablative Laser Treatments Such As Fractionated Co2 Or Er:yag Laser Resurfacing? Optimize Safety And Results

For ablative CO₂ or Er:YAG resurfacing, clinics should use a documented protocol covering patient selection, skin preparation, infection prevention, medication management, and treatment-room safety. Begin conditioning and photoprotection several weeks before treatment, screen carefully for HSV and abnormal scarring, manage pigmentation risk, and stop potentially irritating products shortly before treatment. Antiviral and antibiotic decisions should be made by the treating clinician according to treatment extent, patient risk, local guidance, and antimicrobial-stewardship principles.

The safest protocol is individualized rather than automatic: optimize the skin, identify contraindications and high-risk features, prevent HSV and pigment complications where indicated, and confirm that anesthesia, eye protection, plume evacuation, and fire controls are ready before treatment.

Establish a Structured Pre-Treatment Assessment

Document medical and treatment history

Record the patient’s skin type, degree of photodamage, treatment indication, prior procedures, medications, allergies, healing history, and immune status. For scar treatment, document scar thickness, pliability, erythema, and any restriction.

Ask specifically about:

Previous or recurrent herpes simplex virus
Active infection, dermatitis, or open wounds in the treatment area
Hypertrophic or keloid scarring
Prior poor wound healing or pigmentary complications
Recent tanning or substantial sun exposure
Medications or conditions that may affect bleeding, immunity, or tissue repair

Examine areas requiring additional assessment

For periorbital treatment, perform an eyelid snap test and assess eyelid laxity. This helps identify patients at increased risk of postoperative malposition, including ectropion.

Do not treat through active herpes lesions or other active infection. Delay the procedure until the affected area has fully cleared and the patient has been reassessed.

Set realistic expectations and obtain consent

Written consent should explain the expected recovery period, wound care requirements, sun avoidance, pigmentary changes, infection risk, HSV reactivation, scarring, prolonged erythema, and the possibility of treatment postponement.

Provide written pre- and post-treatment instructions and confirm that the patient understands medication changes, appointment timing, and when to contact the clinic.

Prepare the Skin Before Resurfacing

Begin conditioning several weeks in advance

Depending on the patient’s skin and the planned treatment, conditioning may begin approximately 2–6 weeks before treatment. Options can include carefully selected superficial glycolic or salicylic acid exfoliation, or topical retinoid therapy prescribed by the treating clinician.

The objective is to create a more uniform, healthier surface and support recovery—not to cause irritation. Conditioning should be adjusted or stopped if the patient develops erythema, dermatitis, excessive dryness, or barrier disruption.

Enforce strict photoprotection

Patients should avoid tanning and use daily broad-spectrum sunscreen with SPF 30 or higher, including effective UVA protection such as zinc oxide or titanium dioxide. This is particularly important for reducing melanocyte activation and the risk of post-inflammatory hyperpigmentation.

Photoprotection should continue after treatment according to the clinic’s wound-healing and follow-up instructions.

Manage hyperpigmentation risk proactively

Patients with darker Fitzpatrick skin types, a history of post-inflammatory hyperpigmentation, or recent tanning may require pretreatment with a pigment-modulating agent. Options described in clinical protocols include hydroquinone, kojic acid, or azelaic acid, selected according to the clinician’s assessment and the patient’s tolerance.

For higher-risk patients, pigment pretreatment may be used for approximately 1–2 months before resurfacing. The chosen agent should be stopped or continued according to the supervising clinician’s specific protocol.

Stop irritating topical products before treatment

Topical retinoids and alpha-hydroxy acid products should generally be discontinued 2–3 days before laser treatment, or earlier if the patient has irritation or a compromised barrier.

The clinic should provide a complete product list rather than relying on the patient to identify retinoids or exfoliants independently. Products that produce significant dryness, peeling, or irritation should not be continued into treatment.

Prevent Infectious Complications

Screen for HSV and plan antiviral prophylaxis

A history of facial or perioral HSV should trigger a documented antiviral plan, especially when treating the face or perioral region. Ablative resurfacing can reactivate HSV even when no lesion is visible at the appointment.

Protocols commonly begin antiviral therapy the day before or 1–2 days before treatment and continue for several days afterward or until re-epithelialization, depending on treatment extent and clinician judgment. The exact medication and dose must follow the prescriber’s instructions, patient factors, and local guidance.

Use antibiotics selectively and deliberately

Ablative resurfacing disrupts the epidermal barrier, so some clinicians prescribe systemic antibacterial prophylaxis, particularly for extensive or deep treatments. However, antibiotics should not be treated as an automatic substitute for sterile technique, wound care, or appropriate patient selection.

The clinic should define when antibiotics are indicated, which agents are appropriate, and how long they should be used. Protocols should account for allergies, local resistance patterns, drug interactions, renal function, and antimicrobial stewardship.

Postpone treatment when infection risk is unacceptable

Defer treatment for active HSV, bacterial infection, significant dermatitis, or another condition that could impair healing. Reschedule only after the condition has resolved and the patient has been re-evaluated.

Plan Anesthesia and Medication Safety

Match anesthesia to treatment depth and area

Localized perioral or periorbital treatment may be managed with topical anesthetic, sometimes combined with local or regional anesthesia. Topical anesthetic under occlusion may be applied for a defined period, such as 90 minutes, and must be removed thoroughly before laser delivery.

Full-face or high-density ablative treatment often requires more than topical anesthesia alone. Depending on treatment depth and patient factors, the plan may include regional blocks, systemic sedation, or general anesthesia under appropriately qualified supervision.

Verify topical anesthetic removal

Before laser delivery, remove topical anesthetic completely and prepare the skin according to the clinic’s antiseptic protocol. If alcohol-based cleansing is used, it must be fully evaporated before firing the laser because residual flammable material creates a fire hazard.

Treat optional adjuncts as optional

Botulinum toxin pretreatment approximately two weeks before resurfacing is described in some protocols to reduce dynamic movement. It is not a universal requirement for ablative laser treatment and should be considered only when clinically relevant to the treatment plan.

Make the Treatment Room Safe Before the Patient Arrives

Confirm wavelength-specific eye protection

For facial resurfacing, use eye protection appropriate to the laser wavelength. When treating eyelid skin, use properly fitted internal metal ocular shields; external shields or goggles may be suitable for other facial areas when they provide adequate protection.

Post laser-warning signage and ensure that all staff in the controlled area wear the required wavelength-specific protective eyewear.

Control fire hazards

Ablative lasers should not be fired near dry gauze, paper products, or exposed oxygen sources, including nasal cannulas. Use appropriate wet barriers or towels around the treatment field and confirm that all flammable materials have been removed or controlled.

The fire-safety plan should address oxygen delivery, drapes, dressings, gauze, alcohol-based preparations, and emergency response.

Arrange continuous plume evacuation

Ablative treatment generates aerosolized tissue plume. Use a dedicated, high-efficiency smoke evacuator continuously and position it close enough to the treatment site to capture plume effectively.

Room ventilation alone should not be treated as an adequate substitute for local plume evacuation.

Understanding the Trade-offs

More aggressive conditioning can increase irritation

Retinoids and exfoliating agents may support more uniform treatment preparation, but excessive use can compromise the barrier and increase inflammation. The correct approach is controlled conditioning, not maximal exfoliation.

Pigment prevention must be balanced against tolerability

Hydroquinone and other pigment-modulating agents may reduce hyperpigmentation risk in selected patients, but irritation itself can worsen inflammation and pigmentation. Use a supervised regimen and stop or modify it if intolerance develops.

Broader prophylaxis is not always better

Antiviral prophylaxis is particularly important for patients with HSV risk and facial ablative procedures. Antibiotic use requires more individualized judgment because unnecessary or prolonged treatment exposes patients to adverse effects and contributes to antimicrobial resistance.

Larger treatment areas increase planning requirements

Full-face, neck, or high-density treatments generally require more extensive planning for anesthesia, medication prophylaxis, wound care, plume control, and follow-up than small localized treatments. A protocol suitable for a small perioral area should not automatically be applied to full-face resurfacing.

How to Apply This to Your Clinic

A practical clinic checklist should include the following:

If your primary focus is patient selection: Document skin type, HSV history, active infection, scarring history, healing risks, eyelid laxity, medications, and treatment goals before scheduling.
If your primary focus is pigment prevention: Require several weeks of sun avoidance and photoprotection, and consider supervised pigment-modulating pretreatment for patients at elevated risk of post-inflammatory hyperpigmentation.
If your primary focus is infection prevention: Establish a clinician-approved antiviral protocol for HSV-risk patients and an individualized antibiotic policy for extensive or high-risk ablative treatments.
If your primary focus is procedural safety: Verify wavelength-specific eye protection, fire controls, plume evacuation, anesthesia planning, and complete removal of flammable topical preparations before every procedure.
If your primary focus is compliance: Give patients signed written instructions covering product discontinuation, sun avoidance, medication timing, postponement criteria, and urgent symptoms.

A consistent, risk-adjusted checklist turns pre-treatment preparation from a collection of habits into a reliable patient-safety system.

Summary Table:

Protocol Category	Key Steps	Timing/Frequency
Patient Assessment	Document skin type, photodamage, medications, HSV history, scarring history; perform eyelid snap test for periorbital treatment	At initial consultation
Skin Conditioning	Use superficial glycolic/salicylic acid or topical retinoids to improve skin uniformity; adjust if irritation occurs	2-6 weeks before treatment
Photoprotection	Strict sun avoidance; daily broad-spectrum SPF 30+ (zinc oxide/titanium dioxide)	Starting 2-6 weeks before, continue post-treatment
Pigment Management	For high-risk patients (darker skin types, PIH history), use hydroquinone, kojic acid, or azelaic acid	1-2 months before treatment
Discontinue Irritants	Stop retinoids and AHAs to avoid barrier disruption	2-3 days before treatment
HSV Prophylaxis	Antiviral therapy for patients with HSV history, especially facial/perioral treatment	Start 1-2 days before, continue until re-epithelialization
Antibiotic Prophylaxis	Selective use for extensive/deep ablations; consider allergies, resistance, stewardship	As per clinician judgment
Anesthesia Planning	Topical, local, regional, or general anesthesia based on treatment extent; ensure complete removal of topical anesthetics	Day of procedure
Eye Protection	Wavelength-specific goggles or internal metal shields for periorbital treatment	Pre-procedure
Fire Safety	No dry gauze, paper, oxygen near laser; use wet barriers; allow alcohol prep to evaporate fully	Pre-procedure
Plume Evacuation	Continuous use of high-efficiency smoke evacuator close to treatment site	During ablation

Ensure your clinic meets the highest safety standards for ablative laser treatments. Partner with BELIS for professional-grade aesthetic equipment and expert guidance. Our portfolio includes advanced CO2 fractional and Er:YAG lasers, along with a full range of aesthetic devices, exclusively for clinics and premium salons. Contact us today to learn how BELIS can enhance your practice's safety and profitability. Get in touch now.